Menu Close

Is neuroleptic malignant syndrome same as malignant hyperthermia?

Is neuroleptic malignant syndrome same as malignant hyperthermia?

Neuroleptic malignant syndrome and malignant hyperthermia share two cardinal clinical features: hypothermia and rigidity. Both syndromes can result in rhabdomyolysis and have high mortality rates if left untreated. This article reviews each syndrome and its pathogenesis and treatment.

Are NMS and malignant hyperthermia the same?

Malignant hyperthermia — A rare genetic disorder, malignant hyperthermia (MH) is usually distinguished from NMS by its clinical setting: occurring with use of potent halogenated inhalational anesthetic agents and succinylcholine.

How can you tell the difference between neuroleptic and malignant syndrome?

However, NMS is characterised by ‘lead-pipe’ rigidity, whilst serotonin syndrome is characterised by hyperreflexia and clonus. Precipitating medicines also allow differentiation. Dopamine antagonists precipitate NMS, whilst serotonergic medicines are indicative of serotonin syndrome.

Does neuroleptic malignant syndrome cause hyperthermia?

Neuroleptic malignant syndrome (NMS) is a rare and life-threatening reaction to the use of any neuroleptic medication. Neuroleptics, also known as antipsychotic medications, treat and manage symptoms of many psychiatric conditions. NMS is characterized by the following: High fever (hyperthermia).

What is neuroleptic syndrome?

Neuroleptic malignant syndrome is a rare but potentially life-threatening reaction to the use of almost any of a group of antipsychotic drugs or major tranquilizers (neuroleptics). These drugs are commonly prescribed for the treatment of schizophrenia and other neurological, mental, or emotional disorders.

What causes malignant hyperthermia?

Malignant hyperthermia is a life-threatening, but treatable reaction to certain anesthesia medications. It’s caused by an inherited gene mutation (change) that affects your muscles. If you have a biological parent or relative who has the mutation, you’re at greater risk for experiencing malignant hyperthermia.

What is malignant hyperthermia?

Malignant hyperthermia is a severe reaction to certain drugs used for anesthesia. This severe reaction typically includes a dangerously high body temperature, rigid muscles or spasms, a rapid heart rate, and other symptoms. Without prompt treatment, the complications caused by malignant hyperthermia can be fatal.

How do you treat NMS?

Medications prescribed as treatment may include skeletal muscle relaxants, such as dantrolene; stimulators of dopamine production and activity, such as bromocriptine; and/or continuous perfusion of central nervous system depressants, such as diazepam.

Is NMS a type of EPS?

One of the cardinal features of NMS is an increasing manifestation of EPS, and the conventional antipsychotic drugs are known to produce EPS in 95% or more of NMS cases. With atypical antipsychotic drugs, the incidence of EPS during NMS is of a similar magnitude.

What is a characteristic of the neuroleptic malignant syndrome?

Symptoms of neuroleptic malignant syndrome usually include very high fever (102 to 104 degrees F), irregular pulse, accelerated heartbeat (tachycardia), increased rate of respiration (tachypnea), muscle rigidity, altered mental status, autonomic nervous system dysfunction resulting in high or low blood pressure.

What drug treats NMS?

In more severe cases of NMS, empiric pharmacologic therapy is typically tried. The two most frequently used medications are bromocriptine mesylate, a dopamine agonist, and dantrolene sodium, a muscle relaxant that works by inhibiting calcium release from the sarcoplasmic reticulum.